Skip to main content
Premium Trial:

Request an Annual Quote

Stephan Toutain and Mary Hiter

Interleukin Genetics has appointed Stephan Toutain as chief commercial officer and Mary Hiter as director of marketing. Toutain joins Interleukin Genetics following three years as a marketing and market access consultant to the biopharmaceutical industry. He previously headed global commercial development for Sarepta Therapeutics and served as general manager for Alexion in Europe. Hiter joins Interleukin Genetics from Abbott Point of Care, where she served for eight years as director of marketing. Prior to Abbott, she held various marketing and product management roles with Cybertronics (now LivaNova), Watson Pharmaceuticals, and Knoll Pharmaceuticals.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.